Hospital Hietzing

Vienna 1130

0 studies enrolling now · 2 studies all time

What they study most

Diabetes Mellitus, Type 1, Leukemia, Myeloid, Acute

Studies at this site

• Volasertib in Combination With Low-dose Cytarabine in Patients Aged 65 Years and Above With Previously Untreated Acute Myeloid Leukaemia, Who Are Ineligible for Intensive Remission Induction Therapy (POLO-AML-2) — Completed
• Empagliflozin as Adjunctive to InSulin thErapy Over 52 Weeks in Patients With Type 1 Diabetes Mellitus (EASE-2) — Completed